462 related articles for article (PubMed ID: 32565500)
1. Individualization of recommendations from the international consensus on continuous glucose monitoring-derived metrics in Japanese children and adolescents with type 1 diabetes.
Urakami T; Yoshida K; Kuwabara R; Mine Y; Aoki M; Suzuki J; Morioka I
Endocr J; 2020 Oct; 67(10):1055-1062. PubMed ID: 32565500
[TBL] [Abstract][Full Text] [Related]
2. Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?
Krajnc M; Kravos Tramšek NA
Eur J Med Res; 2023 Mar; 28(1):111. PubMed ID: 36882852
[TBL] [Abstract][Full Text] [Related]
3. Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes.
Babaya N; Noso S; Hiromine Y; Taketomo Y; Niwano F; Yoshida S; Yasutake S; Kawabata Y; Ikegami H
Sci Rep; 2021 Feb; 11(1):4006. PubMed ID: 33597626
[TBL] [Abstract][Full Text] [Related]
4. Significance of "Time below Range" as a Glycemic Marker Derived from Continuous Glucose Monitoring in Japanese Children and Adolescents with Type 1 Diabetes.
Urakami T; Yoshida K; Kuwabara R; Mine Y; Aoki M; Suzuki J; Morioka I
Horm Res Paediatr; 2020; 93(4):251-257. PubMed ID: 32950993
[TBL] [Abstract][Full Text] [Related]
5. Safety and Glycemic Outcomes During the MiniMed
Pihoker C; Shulman DI; Forlenza GP; Kaiserman KB; Sherr JL; Thrasher JR; Buckingham BA; Kipnes MS; Bode BW; Carlson AL; Lee SW; Latif K; Liljenquist DR; Slover RH; Dai Z; Niu F; Shin J; Jonkers RAM; Roy A; Grosman B; Vella M; Cordero TL; McVean J; Rhinehart AS; Vigersky RA;
Diabetes Technol Ther; 2023 Nov; 25(11):755-764. PubMed ID: 37782145
[No Abstract] [Full Text] [Related]
6. Exploring the inter-subject variability in the relationship between glucose monitoring metrics and glycated hemoglobin for pediatric patients with type 1 diabetes.
Bosoni P; Calcaterra V; Tibollo V; Malovini A; Zuccotti G; Mameli C; Sacchi L; Bellazzi R; Larizza C
J Pediatr Endocrinol Metab; 2021 May; 34(5):619-625. PubMed ID: 33823102
[TBL] [Abstract][Full Text] [Related]
7. Clinical use of a 180-day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes.
Irace C; Cutruzzolà A; Nuzzi A; Assaloni R; Brunato B; Pitocco D; Tartaglione L; Di Molfetta S; Cignarelli A; Laviola L; Citro G; Lovati E; Gnasso A; Tweden KS; Kaufman FR
Diabetes Obes Metab; 2020 Jul; 22(7):1056-1061. PubMed ID: 32037699
[TBL] [Abstract][Full Text] [Related]
8. The Importance of Continuous Glucose Monitoring-derived Metrics Beyond HbA1c for Optimal Individualized Glycemic Control.
Yoshii H; Mita T; Katakami N; Okada Y; Osonoi T; Aso K; Kurozumi A; Wakasugi S; Sato F; Ishii R; Gosho M; Shimomura I; Watada H
J Clin Endocrinol Metab; 2022 Sep; 107(10):e3990-e4003. PubMed ID: 35908248
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of the freestyle libre 2 flash glucose monitoring system on diabetes-self-management practices and glycemic parameters among patients with type 1 diabetes using insulin pump.
Al Hayek AA; Robert AA; Al Dawish MA
Diabetes Metab Syndr; 2021; 15(5):102265. PubMed ID: 34488057
[TBL] [Abstract][Full Text] [Related]
10. Significance of the CGM metric of time in range in children and adolescents with type 1 diabetes.
Urakami T
Endocr J; 2022 Sep; 69(9):1035-1042. PubMed ID: 36002301
[TBL] [Abstract][Full Text] [Related]
11. Time In Range in Children with Type 1 Diabetes Using Treatment Strategies Based on Nonautomated Insulin Delivery Systems in the Real World.
Cherubini V; Bonfanti R; Casertano A; De Nitto E; Iannilli A; Lombardo F; Maltoni G; Marigliano M; Bassi M; Minuto N; Mozzillo E; Rabbone I; Rapini N; Rigamonti A; Salzano G; Scaramuzza A; Schiaffini R; Tinti D; Toni S; Zagaroli L; Zucchini S; Maffeis C; Gesuita R
Diabetes Technol Ther; 2020 Jul; 22(7):509-515. PubMed ID: 32073311
[No Abstract] [Full Text] [Related]
12. Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials.
Maiorino MI; Signoriello S; Maio A; Chiodini P; Bellastella G; Scappaticcio L; Longo M; Giugliano D; Esposito K
Diabetes Care; 2020 May; 43(5):1146-1156. PubMed ID: 32312858
[TBL] [Abstract][Full Text] [Related]
13. A Comparison of Two Hybrid Closed-Loop Systems in Italian Children and Adults With Type 1 Diabetes.
Bassi M; Teliti M; Lezzi M; Iosca A; Strati MF; Carmisciano L; d'Annunzio G; Minuto N; Maggi D
Front Endocrinol (Lausanne); 2021; 12():802419. PubMed ID: 35116007
[TBL] [Abstract][Full Text] [Related]
14. Time spent outside of target glucose range for young children with type 1 diabetes: a continuous glucose monitor study.
DiMeglio LA; Kanapka LG; DeSalvo DJ; Anderson BJ; Harrington KR; Hilliard ME; Laffel LM; Tamborlane WV; Van Name MA; Wadwa RP; Willi SM; Woerner S; Wong JC; Miller KM;
Diabet Med; 2020 Aug; 37(8):1308-1315. PubMed ID: 32096282
[TBL] [Abstract][Full Text] [Related]
15. Relationships between HbA1c and continuous glucose monitoring metrics of glycaemic control and glucose variability in a large cohort of children and adolescents with type 1 diabetes.
Piona C; Marigliano M; Mozzillo E; Rosanio F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Delvecchio M; Maffeis C
Diabetes Res Clin Pract; 2021 Jul; 177():108933. PubMed ID: 34216681
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with glycemic variability in children with type 1 diabetes mellitus based on flash glucose monitoring system.
Zhang L; Guo K; Xu Y; Bai J; Ma Y; Fu L; Liu J; Hu K; Li X; Jiang H; Yang L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):462-468. PubMed ID: 35545341
[TBL] [Abstract][Full Text] [Related]
17. Comparison of flash glucose monitoring with real time continuous glucose monitoring in children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion.
Massa GG; Gys I; Bevilacqua E; Wijnands A; Zeevaert R
Diabetes Res Clin Pract; 2019 Jun; 152():111-118. PubMed ID: 31121275
[TBL] [Abstract][Full Text] [Related]
18. The Optimal "Time in Range" and "Time below Range" are Difficult to Coordinate in Patients with Type 1 Diabetes.
Sekiguchi S; Yamada E; Nakajima Y; Matsumoto S; Yoshino S; Horiguchi K; Ishida E; Uehara R; Okada S; Yamada M
Tohoku J Exp Med; 2021 Nov; 255(3):221-227. PubMed ID: 34759118
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes.
Nørgaard SK; Mathiesen ER; Nørgaard K; Ringholm L
Diabetes Technol Ther; 2021 Oct; 23(10):665-672. PubMed ID: 34086494
[No Abstract] [Full Text] [Related]
20. An Assessment of Clinical Continuous Glucose Monitoring Targets for Older and High-Risk People Living with Type 1 Diabetes.
O'Neal DN; Cohen O; Vogrin S; Vigersky RA; Jenkins AJ;
Diabetes Technol Ther; 2023 Feb; 25(2):108-115. PubMed ID: 36315189
[No Abstract] [Full Text] [Related]
[Next] [New Search]